STADA Arzneimittel AG logo

SAZ - STADA Arzneimittel AG Share Price

€83.6 0.1  0.1%

Last Trade - 16/09/19

Sector
Healthcare
Size
Large Cap
Market Cap £4.65bn
Enterprise Value £5.57bn
Revenue £2.21bn
Position in Universe 157th / 992
Bullish
Bearish
Unlock SAZ Revenue
Momentum
Relative Strength (%)
1m
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Margin of Safety
Qualifying GuruScreens
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

SAZ Revenue Unlock SAZ Revenue

Net Income

SAZ Net Income Unlock SAZ Revenue

Normalised EPS

SAZ Normalised EPS Unlock SAZ Revenue

PE Ratio Range

SAZ PE Ratio Range Unlock SAZ Revenue

Dividend Yield Range

SAZ Dividend Yield Range Unlock SAZ Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2019
31st Dec 2020
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
SAZ EPS Forecasts Unlock SAZ Revenue
Profile Summary

Stada Arzneimittel AG is a Germany-based holding company active in the pharmaceutical sector and healthcare market. The Company develops and markets products with off-patent active pharmaceutical ingredients. The Company’s primary business segments are Generics and Branded Products. The Generics segment comprises low-priced and active-ingredient products. The Branded Products segment focuses on multisource products accessible without active ingredient research, notably anti-enzymatic food intolerance drugs that are marketed by the subsidiary SCIOTEC Diagnostics Technologies. The Company's generic drugs are marketed by the Group subsidiary, STADApharm GmbH. Non-core activities of the Company encompass Commercial Business segment, which includes activities with primarily trading character such as wholesaling activities. The Company operates STADA Pharmaceuticals Australia Pty Ltd and STADA IT SOLUTIONS DOO as subsidiaries.

Directors
Last Annual December 31st, 2018
Last Interim June 30th, 2019
Public Since August 24, 2004
No. of Shareholders: 3,980
No. of Employees: 10,435
Sector Healthcare
Industry Pharmaceuticals
Index
Exchange Dusseldorf Stock Exchange
Shares in Issue 0.000
Free Float (0.0%)
Eligible for
ISAs
SIPPs
SAZ Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
© Stockopedia 2019, Thomson Reuters, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.